化合物简介
Foretinib is an experimental drug candidate for the treatment of cancer. It was discovered by Exelixis and is under development by GlaxoSmithKline. About 10 Phase II clinical trials have been run. As of October 2015[update] no phase III trials are registered.
基本信息
中文名称
2-溴-1-(4-氟苯基)-1-丁酮
英文名称
N-(3-Fluoro-4-((6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl)-oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
中文别名
N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N-(4-氟苯基)环丙烷-1,1-二甲酰胺
英文别名
4-(4-(o-Methoxyphenyl)piperazinyl)-1-(3,4,5-trimethoxyphenyl)-1-butanol dihydrochloride、4-[4-(2-methoxyphenyl)piperazin-1-yl]-1-(3,4,5-trimethoxyphenyl)butan-1-ol dihydrochloride、Foretinib、4-(4-Hydroxy-4-(3,4,5-trimethoxyphenyl)butyl)-1-(o-methoxyphenyl)piperazine dihydrochloride、N1-{3-fluoro-4-[(6-(methyloxy)-7-{[3-(4-morpholinyl)propyl]oxy}-4-quinolinyl)oxy]phenyl}-N1\'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide、N-[3-fluoro-4-([6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl]oxy)phenyl]-N\'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide、1-Butanol,4-(4-(o-methoxyphenyl)piperazinyl)-1-(3,4,5-trimethoxyphenyl)-,dihydrochloride
CAS号
849217-64-7
分子式
C34H34F2N4O6
分子量
632.654
精确质量
632.245
PSA
116.45
LOGP
5.9834
编号系统
UNII
81FH7VK1C4
物化性质
密度
1.372g/cm3
沸点
828.475ºC at 760 mmHg
闪点
454.846ºC
折射率
1.649
合成路线
上游原料
共找到6个上游原料 >